Researchers from the Tumor Profiler consortium have combined single-cell multi-omics and functional profiling for 21 AML ...

Obecabtagene autoleucel (obe-cel; Aucatzyl) has been approved by the FDA to treat patients with relapsed or refractory B-cell ...

FDA approves Autolus Therapeutics' Aucatzyl for adults with relapsed or refractory B-cell precursor acute lymphoblastic ...

Researchers sought to determine whether DNA methylation markers could be helpful in risk stratification for patients with AML and normal cytogenetics.

The technology accurately detects the presence of these gene fusions in acute promyelocytic leukemia ... Radon, Even at Levels Below EPA Guideline for Mitigation, Is Linked to Childhood Leukemia ...

A simple rise in the number of factors did not consistently increase the risk for leukemia. Children with irradiation but without either of the pathologic conditions did not show a greater risk ...

Acute myeloid leukemia (AML) is a blood cell cancer that is estimated to cause ∼100,000 deaths worldwide each year. (1) Current standard of care includes treatment with chemotherapeutic agents, newer ...

Harvey Weinstein, the disgraced Hollywood mogul whose alleged sexual misconduct fueled the #MeToo movement and who was recently indicted on new charges, has chronic myeloid leukemia, two sources ...

Oct 21 (Reuters) - Former Hollywood producer Harvey Weinstein has chronic myeloid leukemia (CML), NBC News reported on Monday, citing sources. Weinstein is currently undergoing treatment for CML ...

Acute lymphocytic leukemia (ALL) five-year survival rate is 70.8% for all ages but over 90% for children Chronic myeloid leukemia (CML) five-year survival rate is 67.8%. Acute myeloid leukemia (AML) ...

Acute Lymphocytic Leukemia, also known as ALL, is one of the most common types of childhood cancers particularly for children aged 10 and under, according to Mayo Clinic specialists. The ...